Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT04274829
NCT04274829CompletedNot Applicable

Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid

University of Cagliari1 site in 1 country300 target enrollmentStarted: January 2010Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
300
Locations
1
Primary Endpoint
Incidence of lymph node metastasis
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Papillary thyroid microcarcinoma (PTMC), defined as a tumor with larger diameter ≤ 1 cm, is considered a tumor with an indolent course and an excellent prognosis. Nevertheless, the incidence of lymph node metastasis in PTMC is not negligible, reaching up to 65% in some series. The aim of this study was to assess the incidence of lymph node metastasis in patients with PTMC and to evaluate predictive factors for lymph node metastasis.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients with papillary microcarcinoma of the thyroid

Exclusion Criteria

  • •Patients with thyroid nodules > 1 cm; incomplete data

Outcomes

Primary Outcomes

Incidence of lymph node metastasis

Time Frame: 1 year

To define the incidence of lymph node metastasis in patients with papillary microcarcinoma

Secondary Outcomes

  • Predicrive factors of lymph node metastasis(1 year)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Fabio Medas

Assistant Professor

University of Cagliari

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Phase 2
Extent of Central Lymph Node Dissection in Papillary Thyroid MicrocarcinomaCarcinoma
NCT01149161Samsung Medical Center2,000
Not yet recruiting
Not Applicable
Multiomics Study of Biological Behavior of Lymph Node Metastasis in Papillary Thyroid CarcinomaLymph Node Cancer MetastaticPapillary Thyroid Carcinoma
NCT06725628Tianhan Zhou2,000
Completed
Phase 1
Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CWSurgeryThyroid Carcinoma
NCT06095362University Medical Center Groningen20
Unknown
Not Applicable
Active Surveillance of Papillary Thyroid MicrocarcinomaThyroid Cancer, Papillary
NCT02952612Dong Jun Lim300
Completed
Not Applicable
Detection of Lymph Node Metastases in Papillary Thyroid Cancer using EMI-137 enhanced Molecular Fluorescent Guided Imaging: a multicentre feasibility and safety study100437391001471310014705Papillary thyroid carcinoma
NL-OMON48718niversitair Medisch Centrum Groningen32